Inicio>>FTY720 phenoxy-biotin

FTY720 phenoxy-biotin

Catalog No.GC43701

FTY720 es un modulador inmunológico que regula a la baja los receptores de esfingosina-1-fosfato (S1P), mejora la actividad del transportador de esfingosina ABCB1 y el transportador de leucotrienos C4 ABCC1 e inhibe la actividad de fosfolipasa A2 citosólica.

Products are for research use only. Not for human use. We do not sell to patients.

FTY720 phenoxy-biotin Chemical Structure

Tamaño Precio Disponibilidad Cantidad
100μg
44,00 $
Disponible
500μg
201,00 $
Disponible
1mg
357,00 $
Disponible
5mg
1.559,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

FTY720 is an immune modulator that down-regulates sphingosine-1-phosphate (S1P) receptors, enhances the activity of the sphingosine transporter ABCB1 and the leukotriene C4 transporter ABCC1 and inhibits cytosolic phospholipase A2 activity. It is known that some of the effects of FTY720 require its phosphorylation by sphingosine kinases in vivo, with FTY720-phosphate binding to and down-regulating S1P receptors. Biotin-FTY720 is a biotin-tagged analog of FTY720. The hydroxy methyl side chain of FTY720 that is targeted for phosphorylation by sphingosine kinases is retained in this analog, suggesting that it would likewise be phosphorylated in vivo.

Reseñas

Review for FTY720 phenoxy-biotin

Average Rating: 5 ★★★★★ (Based on Reviews and 7 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for FTY720 phenoxy-biotin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.